 Judith Shlay
Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexually Transmitted Diseases | 11 | 2020 | 155 | 2.530 |
Why?
| | Text Messaging | 7 | 2022 | 152 | 2.430 |
Why?
| | School Health Services | 7 | 2015 | 206 | 2.340 |
Why?
| | Sexual Health | 6 | 2022 | 46 | 2.340 |
Why?
| | Immunization Programs | 6 | 2015 | 205 | 2.120 |
Why?
| | Pregnancy in Adolescence | 4 | 2017 | 80 | 1.600 |
Why?
| | Opioid-Related Disorders | 3 | 2022 | 413 | 1.340 |
Why?
| | Safety-net Providers | 2 | 2020 | 95 | 1.260 |
Why?
| | Sexual Behavior | 10 | 2022 | 440 | 1.110 |
Why?
| | Influenza Vaccines | 4 | 2015 | 497 | 1.080 |
Why?
| | Condoms | 5 | 2016 | 113 | 1.050 |
Why?
| | Reimbursement Mechanisms | 3 | 2015 | 77 | 0.990 |
Why?
| | Ambulatory Care Facilities | 5 | 2013 | 213 | 0.870 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2014 | 88 | 0.870 |
Why?
| | Analgesics, Opioid | 4 | 2022 | 771 | 0.800 |
Why?
| | Colorado | 15 | 2020 | 4099 | 0.800 |
Why?
| | Pregnancy, Unwanted | 3 | 2009 | 13 | 0.780 |
Why?
| | Body Composition | 7 | 2010 | 590 | 0.740 |
Why?
| | Family Planning Services | 2 | 2013 | 68 | 0.720 |
Why?
| | Attitude to Health | 2 | 2014 | 406 | 0.720 |
Why?
| | Contraception Behavior | 2 | 2016 | 81 | 0.700 |
Why?
| | Papillomavirus Infections | 6 | 2013 | 261 | 0.680 |
Why?
| | Contraception | 5 | 2022 | 117 | 0.670 |
Why?
| | HIV Infections | 12 | 2013 | 2469 | 0.640 |
Why?
| | Influenza, Human | 2 | 2014 | 546 | 0.620 |
Why?
| | Patient Participation | 2 | 2019 | 359 | 0.610 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 98 | 0.610 |
Why?
| | Anti-HIV Agents | 4 | 2009 | 666 | 0.610 |
Why?
| | Adolescent | 25 | 2022 | 17837 | 0.570 |
Why?
| | Parental Consent | 2 | 2014 | 22 | 0.570 |
Why?
| | Reverse Transcriptase Inhibitors | 2 | 2008 | 82 | 0.570 |
Why?
| | Sex Education | 1 | 2016 | 30 | 0.540 |
Why?
| | Parents | 2 | 2014 | 1186 | 0.530 |
Why?
| | Papanicolaou Test | 4 | 2013 | 39 | 0.510 |
Why?
| | Vaginal Smears | 4 | 2013 | 50 | 0.510 |
Why?
| | Adolescent Health Services | 1 | 2015 | 68 | 0.480 |
Why?
| | Female | 45 | 2022 | 59488 | 0.470 |
Why?
| | Financing, Government | 1 | 2014 | 40 | 0.460 |
Why?
| | Minority Health | 1 | 2014 | 19 | 0.460 |
Why?
| | Social Values | 1 | 2014 | 36 | 0.450 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2014 | 99 | 0.440 |
Why?
| | Pregnancy | 14 | 2022 | 5517 | 0.420 |
Why?
| | Delivery of Health Care | 3 | 2022 | 833 | 0.420 |
Why?
| | Health Care Costs | 2 | 2014 | 381 | 0.410 |
Why?
| | Adult | 31 | 2020 | 30542 | 0.410 |
Why?
| | Humans | 50 | 2022 | 114654 | 0.400 |
Why?
| | Geographic Information Systems | 1 | 2011 | 37 | 0.380 |
Why?
| | Health Promotion | 3 | 2022 | 686 | 0.370 |
Why?
| | Tumor Virus Infections | 1 | 2011 | 43 | 0.370 |
Why?
| | Stavudine | 2 | 2008 | 8 | 0.370 |
Why?
| | Dideoxynucleosides | 2 | 2008 | 20 | 0.370 |
Why?
| | Male | 28 | 2020 | 55579 | 0.370 |
Why?
| | Lamivudine | 2 | 2008 | 59 | 0.360 |
Why?
| | Social Support | 1 | 2014 | 528 | 0.350 |
Why?
| | Subcutaneous Fat | 3 | 2010 | 70 | 0.330 |
Why?
| | Vaccines | 1 | 2014 | 375 | 0.330 |
Why?
| | Public Health | 1 | 2013 | 433 | 0.320 |
Why?
| | Anti-Retroviral Agents | 4 | 2013 | 207 | 0.320 |
Why?
| | Vaccination | 3 | 2013 | 1204 | 0.310 |
Why?
| | Zidovudine | 1 | 2008 | 77 | 0.300 |
Why?
| | Insurance, Health | 3 | 2015 | 244 | 0.290 |
Why?
| | Middle Aged | 20 | 2019 | 26732 | 0.280 |
Why?
| | Costs and Cost Analysis | 2 | 2020 | 196 | 0.280 |
Why?
| | HIV Protease Inhibitors | 1 | 2007 | 64 | 0.270 |
Why?
| | Health Status | 1 | 2011 | 722 | 0.270 |
Why?
| | Primary Health Care | 2 | 2014 | 1512 | 0.260 |
Why?
| | Papillomavirus Vaccines | 3 | 2013 | 223 | 0.260 |
Why?
| | Indians, North American | 1 | 2011 | 570 | 0.250 |
Why?
| | Patient Compliance | 1 | 2009 | 525 | 0.250 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 975 | 0.250 |
Why?
| | Risk Assessment | 3 | 2013 | 2968 | 0.250 |
Why?
| | Antiretroviral Therapy, Highly Active | 5 | 2010 | 256 | 0.240 |
Why?
| | Physicians | 1 | 2012 | 772 | 0.230 |
Why?
| | Community-Institutional Relations | 2 | 2015 | 89 | 0.230 |
Why?
| | Diagnostic Errors | 1 | 2005 | 149 | 0.230 |
Why?
| | HIV-1 | 4 | 2011 | 768 | 0.220 |
Why?
| | United States | 9 | 2020 | 12179 | 0.210 |
Why?
| | Follow-Up Studies | 6 | 2017 | 4411 | 0.210 |
Why?
| | Program Evaluation | 3 | 2016 | 822 | 0.210 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2013 | 1183 | 0.200 |
Why?
| | Focus Groups | 2 | 2014 | 383 | 0.200 |
Why?
| | Reproductive Health | 1 | 2022 | 71 | 0.200 |
Why?
| | Pelvic Inflammatory Disease | 1 | 2022 | 9 | 0.200 |
Why?
| | Intrauterine Devices | 1 | 2022 | 24 | 0.200 |
Why?
| | Electronic Health Records | 2 | 2022 | 800 | 0.200 |
Why?
| | Long-Acting Reversible Contraception | 1 | 2022 | 24 | 0.190 |
Why?
| | Patient Acceptance of Health Care | 3 | 2014 | 681 | 0.190 |
Why?
| | Human papillomavirus 16 | 2 | 2011 | 25 | 0.190 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 1727 | 0.180 |
Why?
| | Heroin | 1 | 2020 | 23 | 0.170 |
Why?
| | Incidence | 4 | 2013 | 2312 | 0.170 |
Why?
| | Allied Health Personnel | 1 | 2020 | 42 | 0.170 |
Why?
| | Prevalence | 5 | 2013 | 2250 | 0.170 |
Why?
| | Lipids | 3 | 2009 | 580 | 0.160 |
Why?
| | Inpatients | 1 | 2022 | 380 | 0.160 |
Why?
| | Drug Prescriptions | 1 | 2020 | 239 | 0.150 |
Why?
| | Multivariate Analysis | 4 | 2009 | 1430 | 0.150 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2013 | 216 | 0.150 |
Why?
| | HIV-Associated Lipodystrophy Syndrome | 2 | 2010 | 17 | 0.150 |
Why?
| | Child | 5 | 2019 | 18407 | 0.150 |
Why?
| | Adipose Tissue | 4 | 2010 | 539 | 0.140 |
Why?
| | Young Adult | 5 | 2019 | 10465 | 0.140 |
Why?
| | Cost-Benefit Analysis | 2 | 2013 | 544 | 0.140 |
Why?
| | Medicaid | 1 | 2020 | 406 | 0.130 |
Why?
| | Machine Learning | 1 | 2020 | 316 | 0.130 |
Why?
| | Reminder Systems | 1 | 2017 | 160 | 0.130 |
Why?
| | Drug Overdose | 1 | 2020 | 292 | 0.130 |
Why?
| | Organizational Case Studies | 1 | 2015 | 69 | 0.120 |
Why?
| | Women's Health | 2 | 2009 | 271 | 0.120 |
Why?
| | Health Plan Implementation | 1 | 2015 | 132 | 0.120 |
Why?
| | Direct Service Costs | 1 | 2014 | 10 | 0.120 |
Why?
| | Cross-Sectional Studies | 6 | 2013 | 4407 | 0.110 |
Why?
| | Mass Screening | 2 | 2013 | 1004 | 0.110 |
Why?
| | Immunization Schedule | 1 | 2015 | 184 | 0.110 |
Why?
| | Cervix Uteri | 2 | 2011 | 45 | 0.110 |
Why?
| | Research Design | 1 | 2019 | 928 | 0.110 |
Why?
| | National Health Programs | 1 | 2013 | 20 | 0.110 |
Why?
| | AIDS Dementia Complex | 1 | 2013 | 50 | 0.110 |
Why?
| | Sex Counseling | 2 | 2003 | 4 | 0.110 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 931 | 0.110 |
Why?
| | Models, Immunological | 1 | 2013 | 92 | 0.100 |
Why?
| | Emergency Medical Services | 1 | 2020 | 590 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 243 | 0.100 |
Why?
| | Time Factors | 4 | 2013 | 6115 | 0.100 |
Why?
| | Hospitalization | 1 | 2020 | 1750 | 0.100 |
Why?
| | Uterine Cervical Dysplasia | 2 | 2011 | 42 | 0.100 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2011 | 28 | 0.100 |
Why?
| | Human papillomavirus 18 | 1 | 2011 | 14 | 0.090 |
Why?
| | Schools | 1 | 2014 | 399 | 0.090 |
Why?
| | Urban Population | 2 | 2004 | 397 | 0.090 |
Why?
| | Self Efficacy | 1 | 2014 | 355 | 0.090 |
Why?
| | Contraceptive Agents, Female | 1 | 2011 | 64 | 0.090 |
Why?
| | Protease Inhibitors | 1 | 2011 | 97 | 0.090 |
Why?
| | Long QT Syndrome | 1 | 2011 | 59 | 0.090 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 493 | 0.090 |
Why?
| | Health Education | 1 | 2013 | 323 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2013 | 478 | 0.080 |
Why?
| | Learning | 1 | 2013 | 350 | 0.080 |
Why?
| | Regression Analysis | 2 | 2009 | 944 | 0.080 |
Why?
| | Pilot Projects | 1 | 2014 | 1373 | 0.080 |
Why?
| | Risk-Taking | 2 | 2002 | 333 | 0.080 |
Why?
| | Life Style | 1 | 2011 | 430 | 0.080 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 927 | 0.080 |
Why?
| | Cohort Studies | 4 | 2008 | 4895 | 0.080 |
Why?
| | Aged | 6 | 2011 | 19068 | 0.080 |
Why?
| | Virology | 1 | 2008 | 19 | 0.080 |
Why?
| | Odds Ratio | 1 | 2009 | 953 | 0.070 |
Why?
| | Risk Factors | 5 | 2011 | 8631 | 0.070 |
Why?
| | Osteoporosis | 1 | 2009 | 226 | 0.070 |
Why?
| | Prospective Studies | 2 | 2009 | 6217 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1394 | 0.060 |
Why?
| | Bone Density | 1 | 2009 | 432 | 0.060 |
Why?
| | Socioeconomic Factors | 1 | 2009 | 1078 | 0.060 |
Why?
| | Didanosine | 1 | 2005 | 13 | 0.060 |
Why?
| | Genital Diseases, Female | 1 | 2005 | 25 | 0.060 |
Why?
| | Vaginosis, Bacterial | 1 | 2004 | 11 | 0.060 |
Why?
| | Urban Health Services | 1 | 2004 | 60 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2015 | 1214 | 0.060 |
Why?
| | Spermatocidal Agents | 1 | 2003 | 5 | 0.060 |
Why?
| | Abortion, Therapeutic | 1 | 2003 | 5 | 0.060 |
Why?
| | CD4 Lymphocyte Count | 3 | 2010 | 257 | 0.060 |
Why?
| | Pregnancy Rate | 1 | 2003 | 55 | 0.050 |
Why?
| | Catheters, Indwelling | 1 | 2003 | 79 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2009 | 2387 | 0.050 |
Why?
| | Hysterectomy | 1 | 2003 | 106 | 0.050 |
Why?
| | Program Development | 2 | 2015 | 341 | 0.050 |
Why?
| | Community Health Centers | 1 | 2002 | 54 | 0.050 |
Why?
| | Postoperative Care | 1 | 2003 | 222 | 0.050 |
Why?
| | Blood Glucose | 2 | 2009 | 1826 | 0.050 |
Why?
| | Contraceptive Agents | 1 | 2022 | 54 | 0.050 |
Why?
| | Risk | 1 | 2004 | 812 | 0.050 |
Why?
| | Insulin Resistance | 2 | 2009 | 1072 | 0.050 |
Why?
| | Forecasting | 1 | 2002 | 330 | 0.050 |
Why?
| | Child, Preschool | 1 | 2014 | 9111 | 0.040 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2004 | 288 | 0.040 |
Why?
| | Counseling | 1 | 2003 | 342 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1691 | 0.040 |
Why?
| | Papillomaviridae | 2 | 2013 | 101 | 0.040 |
Why?
| | Insulin | 2 | 2009 | 2078 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2002 | 1075 | 0.040 |
Why?
| | Logistic Models | 1 | 2004 | 1840 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2010 | 224 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2003 | 632 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2022 | 12544 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 1796 | 0.040 |
Why?
| | Viral Load | 2 | 2011 | 405 | 0.030 |
Why?
| | Electric Impedance | 2 | 2007 | 100 | 0.030 |
Why?
| | Motivation | 1 | 2020 | 494 | 0.030 |
Why?
| | Automation | 1 | 2015 | 73 | 0.030 |
Why?
| | Cell Phone | 1 | 2015 | 76 | 0.030 |
Why?
| | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2013 | 15 | 0.030 |
Why?
| | Epidemiological Monitoring | 1 | 2013 | 47 | 0.030 |
Why?
| | Data Collection | 1 | 2015 | 620 | 0.030 |
Why?
| | Sex Factors | 2 | 2008 | 1715 | 0.020 |
Why?
| | Coitus | 1 | 2011 | 27 | 0.020 |
Why?
| | Sentinel Surveillance | 1 | 2011 | 38 | 0.020 |
Why?
| | Needs Assessment | 1 | 2013 | 314 | 0.020 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2011 | 54 | 0.020 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2010 | 13 | 0.020 |
Why?
| | Radionuclide Imaging | 1 | 2010 | 115 | 0.020 |
Why?
| | Sexual Partners | 1 | 2011 | 161 | 0.020 |
Why?
| | Health Behavior | 1 | 2015 | 704 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 5044 | 0.020 |
Why?
| | Hip Joint | 1 | 2009 | 126 | 0.020 |
Why?
| | Adolescent Behavior | 1 | 2013 | 489 | 0.020 |
Why?
| | Lumbar Vertebrae | 1 | 2009 | 209 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 718 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 1842 | 0.020 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2008 | 125 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2008 | 182 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2011 | 9087 | 0.020 |
Why?
| | Prognosis | 1 | 2013 | 3327 | 0.020 |
Why?
| | Liver Diseases | 1 | 2008 | 255 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 993 | 0.020 |
Why?
| | Anthropometry | 1 | 2005 | 182 | 0.020 |
Why?
| | Metronidazole | 1 | 2004 | 19 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2009 | 367 | 0.010 |
Why?
| | Verbal Behavior | 1 | 2004 | 43 | 0.010 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2004 | 152 | 0.010 |
Why?
| | Device Removal | 1 | 2003 | 126 | 0.010 |
Why?
| | RNA, Viral | 1 | 2005 | 565 | 0.010 |
Why?
| | Anti-Infective Agents | 1 | 2004 | 225 | 0.010 |
Why?
| | Recurrence | 1 | 2004 | 935 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 4622 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2004 | 668 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2285 | 0.010 |
Why?
| | Age Factors | 1 | 2007 | 2894 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1381 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 1958 | 0.010 |
Why?
| | Pain | 1 | 2003 | 705 | 0.010 |
Why?
|
|
Shlay's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|